HROW:NASDAQ
Harrow Inc
30,52 USD
arrow_downward
-0,33%(-0,10) 1D
30,52 USD
0,00% (0,00)
bedtimeAfter hours
Closed: 8-окт., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HROW...
Open
30,35 USD
High
31,11 USD
Low
30,00 USD
Mkt. cap
1,14 млд
Avg. vol.
550,19 миң
Volume
566,00 миң
52-wk high
54,85 USD
52-wk low
28,54 USD
EPS
-1,00 USD
Beta
0,19
Shares outstanding
37,49 млн
No. of employees
373
Open
30,35 USD
High
31,11 USD
Low
30,00 USD
Mkt. cap
1,14 млд
Avg. vol.
550,19 миң
Volume
566,00 миң
52-wk high
54,85 USD
52-wk low
28,54 USD
EPS
-1,00 USD
Beta
0,19
Shares outstanding
37,49 млн
No. of employees
373
News stories
From web sources and news partners
Seeking Alpha
·
9 саат мурун
Harrow: Q3 Needs To Prove The Turnaround Is Real (NASDAQ:HROW)
Yahoo Finance Singapore
·
21 саат мурун
Is Harrow (HROW) Undervalued On Growing Conference Buzz Around Its Ophthalmic Pipeline?
Simply Wall Street
·
21 саат мурун
Is Harrow (HROW) Cheap After New Eye Drug Data Took Center Stage?
The Business Journals
·
3 күн мурун
Harrow invests $30 million in new pharmaceutical as it builds portfolio
Profile
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
Since 2014, Harrow has started six healthcare businesses, including ImprimisRx, an ophthalmic-focused pharmaceutical company. In 2017, Harrow started and funded Eton Pharmaceuticals with a $20 million Series A financing, and Eton is now a publicly traded company. In 2017, Harrow started Surface Pharmaceuticals, hiring Dr. Kamran Hosseini to be its chief executive officer. Surface was funded with a $20 million Series A financing with Flying L Partners leading the round. In 2018, Harrow started Melt Pharmaceuticals and announced an $11 million Series A financing.
In 2019, Harrow hired founder and former CEO of Doxy.me, Drew Livingston, as its chief innovation officer. Livingston is the senior executive of Harrow's Visionology.com telemedicine subsidiary. Wikipedia
About Harrow Inc
CEOMark L. Baum Esq.
Employees373
Founded2012
HeadquartersНашвилл, Теннесси, Америка Кошмо Штаттары
SectorPharmaceutical industry
Websiteharrow.com